Experientia

, Volume 27, Issue 5, pp 539–541 | Cite as

Species differences in the influence of chlorothiazide on curarization

  • G. Suarez-Kurtz
  • L. G. Paul
Specialia Pharmacologica
  • 10 Downloads

Keywords

Species Difference Action Antagoniste Chlorothiazide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Résumé

Chez le Chien, le Chat, le Cobaye et le Rat, le chlorothiazide est antagoniste de lad-tubocurarine. Chez le Lapin, le chlorothiazide potentialise la paralysied-tubocurarinique, mais exerce une action antagoniste vis-à-vis d'autres curarimimétiques. L'administration préalable de phénylbutazone transforme en antagonisme la synergie entre le chlorothiazide et lad-tubocurarine.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    J. Cheymol andF. Bourillet, Therapie14, 1068 (1959).PubMedGoogle Scholar
  2. 2.
    G. L. Gessa andW. Ferrari, Arch. int. Pharmacodyn144, 258 (1963).PubMedGoogle Scholar
  3. 3.
    L. G. Paulo, Thesis, Instituto de Ciencias Biomedicas, UFRJ, Rio de Janeiro (1970).Google Scholar
  4. 4.
    A. H. Anton, J. Pharmac. exp. Ther.129, 282 (1960).Google Scholar
  5. 5.
    A. H. Anton, J. Pharmac. exp. Ther.134, 291 (1961).Google Scholar
  6. 6.
    B. B. Brodie, Proc. R. Soc. Med.58, 946 (1965).PubMedGoogle Scholar
  7. 7.
    L. Aladjemoff, S. Dickstein andE. Shafrir, J. Pharmac. exp. Ther.123, 43 (1958).Google Scholar
  8. 8.
    H. M. Solomon, J. J. Schrogie andD. Williams, Biochem. Pharmac.17, 143 (1968).CrossRefGoogle Scholar
  9. 9.
    C. T. Dollery, D. Emslie-Smith andD. F. Muggleton, Br. J. Pharmac.17, 488 (1961).Google Scholar
  10. 10.
    B. K. Martin, Nature, Lond.207, 274 (1965).Google Scholar
  11. 11.
    A. Goldstein, Pharmac. Rev.1, 102 (1948).Google Scholar

Copyright information

© Birkhäuser Verlag 1971

Authors and Affiliations

  • G. Suarez-Kurtz
    • 1
  • L. G. Paul
    • 1
  1. 1.Department of Pharmacology and Experimental TherapeuticsInstituto de Ciencias Biologicas, UFRJRio de JaneiroBrasil

Personalised recommendations